Concept Award – HT942524RCRPCA
- up to USD$100,000 over 2 years
- pre-proposals due 15 July 2024
- Supports high-risk/high-reward research that is in the earliest stages of idea development or an untested theory that addresses an important problem related to rare cancers.
- anticipated outcome is proof-of-concept
- must address at least one of the focus areas of Biology and Etiology; Research Model; and/or Therapy
- preliminary data not required
- clinical trials not allowed
- Document: Funding Announcement: HT924524RCRPCA_GG
Idea Development Award – HT942524RCRPIDA
- up to USD$350,000 over 3 years
- pre-proposals due 17 June 2024
- supports high-risk/high-reward research with the potential to yield impactful data in the rare cancers field
- must address at least one of the focus areas of Biology and Etiology; Research Model; and/or Therapy
- preliminary data with disease-specific rationale required
- clinical trials not allowed
- Document: Funding Announcement: HT924524RCRPIDA_GG
Resource and Community Development Award – HT942524RCRPRCDA
- up to USD$800,000 over 4 years
- pre-proposals due 17 June 2024
- supports platform development or infrastructure that can be applied to type(s) or sub-type(s) of rare cancers
- must emphasis research resources development to facilitate collaboration and information sharing among stakeholders such as researchers, patients, family members, caregivers, clinicians etc
- preliminary data not required, but allowed. Translational research and clinical studies may be included
- must address the Platform Development focus area
- clinical trials not allowed
- Document: Funding Announcement: HT924524RCRPRCDA_GG
